A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

XFOR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.08%

Insider Buying (Last 12 Months): $30,000.00

Insider Selling (Last 12 Months): $790,527.04

X4 Pharmaceuticals Insider Trading History Chart

X4 Pharmaceuticals Share Price & Price History

^$1.36

▲ +0.1 (7.94%)

As of 04/22/2024 01:00 AM ET

Days: 30 | 90 | 365

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

X4 Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2024	Adam S. Mostafa	CFO	Sell	52,500	$0.88	$46,200.00
3/11/2024	Arthur Taveras	Insider	Sell	14,235	$0.88	$12,526.80	234,301
3/11/2024	Mary Dibiase	COO	Sell	15,409	$0.88	$13,559.92	291,752
3/11/2024	Paula Ragan	CEO	Sell	49,678	$0.88	$43,716.64	765,068
2/12/2024	Adam S. Mostafa	CFO	Sell	27,721	$1.01	$27,998.21	52,500
2/12/2024	Arthur Taveras	Insider	Sell	787	$1.01	$794.87	248,536
2/12/2024	Mary Dibiase	COO	Sell	3,683	$1.01	$3,719.83	307,161
2/12/2024	Paula Ragan	CEO	Sell	21,695	$1.01	$21,911.95	814,746
11/3/2023	Paula Ragan	CEO	Sell	39,906	$0.90	$35,915.40	836,441
11/1/2023	Adam S. Mostafa	CFO	Sell	230,645	$0.73	$168,370.85	80,221
11/1/2023	Mark Baldry	Insider	Sell	10,257	$0.73	$7,487.61	24,690
11/1/2023	Mary Dibiase	COO	Sell	67,695	$0.73	$49,417.35	310,844
11/1/2023	Paula Ragan	CEO	Sell	199,531	$0.73	$145,657.63	876,347
9/8/2023	Mary Dibiase	COO	Sell	2,642	$1.25	$3,302.50	147,894
8/18/2023	Michael S Wyzga	Director	Buy	25,000	$1.20	$30,000.00	76,667
8/10/2023	Murray Stewart	Insider	Sell	130,056	$1.06	$137,859.36	146,504
6/30/2023	Adam S. Mostafa	CFO	Sell	2,641	$1.89	$4,991.49	80,221
6/30/2023	Mary Dibiase	COO	Sell	464	$1.89	$876.96	150,536
6/23/2023	Adam S. Mostafa	CFO	Sell	5,417	$1.93	$10,454.81	82,862
6/23/2023	Mary Dibiase	COO	Sell	857	$1.93	$1,654.01	151,000
6/23/2023	Paula Ragan	CEO	Sell	6,724	$1.92	$12,910.08	543,797
6/15/2023	Adam S. Mostafa	CFO	Sell	5,417	$2.22	$12,025.74	88,279
6/15/2023	Mary Dibiase	COO	Sell	857	$2.23	$1,911.11	151,857
6/15/2023	Paula Ragan	CEO	Sell	6,724	$2.23	$14,994.52	550,521
5/31/2023	Paula Ragan	CEO	Sell	6,292	$1.95	$12,269.40	557,245
2/13/2023	Adam S. Mostafa	CFO	Sell	27,721	$0.93	$25,780.53	146,196
2/13/2023	Arthur Taveras	Insider	Sell	928	$0.93	$863.04	103,179
2/13/2023	Mary Dibiase	COO	Sell	4,348	$0.93	$4,043.64	170,906
2/13/2023	Paula Ragan	CEO	Sell	21,695	$0.93	$20,176.35	613,215
6/3/2022	Paula Ragan	CEO	Sell	6,292	$1.21	$7,613.32	661,806
8/17/2021	Adam S. Mostafa	CFO	Sell	10,832	$5.10	$55,243.20
8/17/2021	Derek M. Meisner	General Counsel	Sell	8,332	$5.10	$42,493.20
8/17/2021	Paula Ragan	CEO	Sell	13,448	$5.10	$68,584.80
7/15/2021	Paula Ragan	CEO	Sell	13,448	$5.78	$77,729.44
6/30/2021	Adam S. Mostafa	CFO	Sell	2,641	$6.64	$17,536.24
6/24/2021	Adam S. Mostafa	CFO	Sell	5,417	$7.01	$37,973.17	139,835
6/24/2021	Derek M Meisner	General Counsel	Sell	4,166	$7.00	$29,162.00	85,228
6/15/2021	Adam S. Mostafa	CFO	Sell	5,417	$7.84	$42,469.28	129,002
6/15/2021	Derek M Meisner	General Counsel	Sell	4,166	$7.84	$32,661.44	76,894
6/2/2021	Paula Ragan	CEO	Sell	2,400	$9.50	$22,800.00

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

SEC Filings (Institutional Ownership Changes) for X4 Pharmaceuticals (NASDAQ:XFOR)

72.03% of X4 Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

X4 Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/18/2024	Kingdon Capital Management L.L.C.	3,473,683	$2.91M	0.4%	+76.0%	2.076%
2/13/2024	Bain Capital Life Sciences Investors LLC	16,915,784	$14.18M	1.4%	+6.0%	10.112%
2/13/2024	Armistice Capital LLC	1,936,000	$1.62M	0.0%	-17.8%	1.157%
1/12/2024	SG Americas Securities LLC	47,668	$40K	0.0%	+38.8%	0.028%
11/22/2023	Polar Capital Holdings Plc	7,500,000	$8.18M	0.1%	-25.0%	4.483%
11/15/2023	GSA Capital Partners LLP	621,587	$0.68M	0.1%	N/A	0.372%
11/15/2023	Armistice Capital LLC	2,356,000	$2.57M	0.0%	-20.8%	1.408%
11/14/2023	Schonfeld Strategic Advisors LLC	586,042	$0.64M	0.0%	-40.4%	0.350%
11/14/2023	Stonepine Capital Management LLC	5,273,685	$5.75M	1.9%	+14.5%	3.152%
11/14/2023	Monashee Investment Management LLC	427,265	$0.47M	0.2%	-25.4%	0.255%
11/7/2023	Barclays PLC	382,134	$0.42M	0.0%	+334.8%	0.232%
10/13/2023	SG Americas Securities LLC	34,340	$37K	0.0%	N/A	0.021%
9/21/2023	Barclays PLC	87,879	$0.17M	0.0%	N/A	0.053%
8/24/2023	Perceptive Advisors LLC	3,545,454	$6.88M	0.2%	-22.0%	2.156%
8/16/2023	Stonepine Capital Management LLC	4,605,263	$8.93M	3.2%	N/A	3.768%
8/15/2023	Bain Capital Life Sciences Investors LLC	15,960,588	$30.96M	3.2%	+30.8%	13.060%
8/14/2023	Polar Capital Holdings Plc	5,000,000	$9.70M	0.1%	N/A	4.091%
8/11/2023	AWM Investment Company Inc.	100,000	$0.19M	0.0%	N/A	0.082%
8/10/2023	Monashee Investment Management LLC	572,784	$1.11M	0.3%	N/A	0.469%
8/10/2023	Private Advisor Group LLC	19,800	$38K	0.0%	N/A	0.016%
8/7/2023	Principal Financial Group Inc.	13,804	$27K	0.0%	N/A	0.011%
8/7/2023	Royce & Associates LP	53,490	$0.10M	0.0%	N/A	0.044%
8/4/2023	American International Group Inc.	59,261	$0.12M	0.0%	N/A	0.048%
7/27/2023	Virtu Financial LLC	15,077	$29K	0.0%	-86.7%	0.012%
7/24/2023	Vontobel Holding Ltd.	45,000	$87K	0.0%	N/A	0.037%
7/19/2023	Grimes & Company Inc.	15,000	$29K	0.0%	N/A	0.012%
5/15/2023	Ghost Tree Capital LLC	850,000	$0.74M	0.2%	-15.0%	0.696%
5/12/2023	Scoggin Management LP	484,796	$0.57M	0.3%	N/A	0.397%
5/12/2023	CIBC Private Wealth Group LLC	41,500	$36K	0.0%	N/A	0.034%
5/10/2023	Landscape Capital Management L.L.C.	42,252	$37K	0.0%	N/A	0.035%
5/10/2023	Simplify Asset Management Inc.	400,000	$0.35M	0.0%	N/A	0.327%
5/1/2023	Virtu Financial LLC	113,489	$99K	0.0%	N/A	0.094%
2/10/2023	NEA Management Company LLC	11,736,793	$11.66M	0.7%	+79.9%	16.952%
2/7/2023	Lynwood Capital Management Inc.	2,155,100	$2.14M	2.6%	N/A	3.113%
11/15/2022	Tri Locum Partners LP	2,504,006	$4.28M	1.2%	+44.0%	3.617%
11/15/2022	Parkman Healthcare Partners LLC	950,000	$1.63M	0.5%	N/A	1.372%
11/15/2022	Bain Capital Life Sciences Investors LLC	6,389,436	$10.93M	1.3%	+111.6%	9.228%
11/14/2022	NEA Management Company LLC	6,523,157	$11.16M	0.6%	N/A	9.422%
11/14/2022	Cormorant Asset Management LP	830,654	$1.42M	0.1%	+698.9%	1.200%
11/14/2022	Point72 Asset Management L.P.	2,546,446	$4.35M	0.0%	+55.9%	3.678%
11/14/2022	Boothbay Fund Management LLC	58,760	$100K	0.0%	-67.3%	0.085%
11/14/2022	AXA S.A.	4,126,460	$7.06M	0.0%	+258.7%	5.960%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	23,065	$39K	0.0%	N/A	0.033%
10/17/2022	LexAurum Advisors LLC	16,000	$27K	0.0%	N/A	0.023%
8/12/2022	Ikarian Capital LLC	1,679,748	$1.62M	0.3%	+22.4%	5.449%
5/12/2022	AIGH Capital Management LLC	997,719	$1.75M	0.4%	-31.9%	3.237%
4/14/2022	Minot Wealth Management LLC	55,000	$96K	0.0%	N/A	0.179%
2/15/2022	Kennedy Capital Management Inc.	131,501	$0.30M	0.0%	N/A	0.532%
2/14/2022	Point72 Asset Management L.P.	1,633,204	$3.74M	0.0%	N/A	6.610%
2/14/2022	Sio Capital Management LLC	276,909	$0.63M	0.2%	-65.6%	1.121%
2/10/2022	Acadian Asset Management LLC	57,270	$0.13M	0.0%	N/A	0.232%
2/10/2022	AIGH Capital Management LLC	1,464,099	$3.35M	1.0%	-12.0%	5.926%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	12,786	$29K	0.0%	N/A	0.052%
12/29/2021	Hudson Bay Capital Management LP	45,893	$0.24M	0.0%	-73.4%	0.186%
11/17/2021	Altium Capital Management LP	804,598	$4.26M	0.9%	N/A	3.256%
11/15/2021	Marshall Wace LLP	25,223	$0.13M	0.0%	+84.0%	0.102%
11/15/2021	AXA S.A.	590,269	$3.12M	0.0%	+3.8%	2.389%
11/12/2021	Trexquant Investment LP	16,625	$88K	0.0%	-34.3%	0.067%
11/12/2021	Renaissance Technologies LLC	120,394	$0.64M	0.0%	-7.9%	0.487%
11/12/2021	AIGH Capital Management LLC	1,664,540	$8.81M	1.9%	+15.7%	6.737%
11/9/2021	Barclays PLC	9,899	$52K	0.0%	-39.7%	0.040%
11/9/2021	BlackRock Inc.	268,450	$1.42M	0.0%	+2.0%	1.086%
11/9/2021	Monashee Investment Management LLC	561,421	$2.97M	0.5%	-2.3%	2.272%
8/27/2021	Endurant Capital Management LP	70,969	$0.46M	0.1%	-53.3%	0.286%
8/25/2021	Marshall Wace LLP	13,709	$89K	0.0%	N/A	0.055%
8/18/2021	Ikarian Capital LLC	2,719,290	$17.68M	1.4%	+4.0%	10.942%
8/17/2021	Worth Venture Partners LLC	334,684	$2.18M	0.8%	N/A	1.347%
8/17/2021	Millennium Management LLC	386,007	$2.51M	0.0%	N/A	1.553%
8/17/2021	Boothbay Fund Management LLC	328,209	$2.13M	0.1%	+6.4%	1.321%
8/17/2021	BVF Inc. IL	847,879	$5.51M	0.2%	-22.3%	3.412%
8/16/2021	LMR Partners LLP	10,152	$66K	0.0%	N/A	0.041%
8/16/2021	Cubist Systematic Strategies LLC	13,135	$85K	0.0%	N/A	0.053%
8/16/2021	State Street Corp	48,480	$0.32M	0.0%	-82.5%	0.195%
8/16/2021	Tibra Equities Europe Ltd	48,400	$0.32M	0.1%	N/A	0.195%
8/16/2021	Goldman Sachs Group Inc.	54,007	$0.35M	0.0%	-35.0%	0.217%
8/16/2021	Marshall Wace LLP	13,709	$89K	0.0%	N/A	0.055%
8/13/2021	Renaissance Technologies LLC	130,694	$0.85M	0.0%	-16.2%	0.526%
8/13/2021	Alpine Global Management LLC	16,877	$0.11M	0.0%	N/A	0.068%
8/13/2021	Northern Trust Corp	68,563	$0.45M	0.0%	-62.0%	0.276%
8/13/2021	Geode Capital Management LLC	161,917	$1.05M	0.0%	-37.3%	0.652%
8/13/2021	Vanguard Group Inc.	897,641	$5.83M	0.0%	+21.9%	3.612%
8/12/2021	AIGH Capital Management LLC	1,438,899	$9.35M	1.7%	N/A	5.790%
8/12/2021	Trexquant Investment LP	25,287	$0.16M	0.0%	N/A	0.102%
8/12/2021	Dimensional Fund Advisors LP	125,297	$0.81M	0.0%	+164.8%	0.504%
8/12/2021	Ergoteles LLC	69,800	$0.45M	0.0%	N/A	0.281%
8/11/2021	Susquehanna International Group LLP	38,900	$0.25M	0.0%	N/A	0.157%
7/19/2021	Minot Wealth Management LLC	17,000	$0.10M	0.0%	N/A	0.069%
5/19/2021	Squarepoint Ops LLC	21,078	$0.18M	0.0%	+22.7%	0.089%
5/18/2021	BVF Inc. IL	1,091,579	$9.40M	0.4%	+37.7%	4.614%
5/18/2021	Orbimed Advisors LLC	1,373,849	$11.83M	0.1%	+26.4%	5.808%
5/17/2021	Endurant Capital Management LP	151,996	$1.31M	0.3%	N/A	0.643%
5/17/2021	DAFNA Capital Management LLC	69,912	$0.60M	0.1%	N/A	0.296%
5/17/2021	Nuveen Asset Management LLC	80,113	$0.69M	0.0%	-4.9%	0.339%
5/17/2021	Abingworth LLP	229,885	$1.96M	0.7%	N/A	0.972%
5/17/2021	Ikarian Capital LLC	1,235,678	$10.64M	0.4%	+49.5%	5.224%
5/17/2021	Goldman Sachs Group Inc.	83,037	$0.72M	0.0%	+48.3%	0.351%
5/14/2021	Dimensional Fund Advisors LP	47,310	$0.41M	0.0%	N/A	0.272%
5/14/2021	Monashee Investment Management LLC	574,712	$4.95M	0.8%	N/A	3.306%
5/13/2021	Barclays PLC	21,245	$0.18M	0.0%	+63.5%	0.122%
5/13/2021	Renaissance Technologies LLC	156,044	$1.34M	0.0%	-3.9%	0.898%

Data available starting January 2016

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase II clinical trial to treat congenital, idiopathic, or cyclic neutropenia. The company is also developing X4P-003, a CXCR4 antagonist for the treatment of CXCR4 dependent disorders and primary immunodeficiencies; and X4P-002, a CXCR4 antagonist for the treatment of blood-brain barrier diseases. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.

Today's Range

Now: $1.36

$1.20

$1.36

50 Day Range

MA: $1.12

$0.84

$1.47

52 Week Range

Now: $1.36

$0.57

$2.58

Volume

2,430,705 shs

Average Volume

2,170,566 shs

Market Capitalization

$228.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Who are the company insiders with the largest holdings of X4 Pharmaceuticals?: X4 Pharmaceuticals' top insider shareholders include:
Paula Ragan (CEO)
Mary Dibiase (COO)
Arthur Taveras (Insider)
Murray Stewart (Insider)
Adam S Mostafa (CFO)
Michael S Wyzga (Director)
Mark Baldry (Insider)
Adam S Mostafa (CFO)
Learn More about top insider investors at X4 Pharmaceuticals.

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad